LA | |
---|---|
Post | - |
Pre | - |
M1 | M2 | M3 | M4 | M5 | M6 | M7 | M8 | M9 | M10 | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|
0 | - | - | - | - | - | - | 12.0 | 166.7 | 7.8 | 1.0 | 187.5 |
1 | - | - | - | - | - | - | 23.8 | 774.5 | 47.0 | 3.0 | 848.3 |
LO1 | LO2 | LO3 | LO4 | LO5a | LO5b | LO6 | Total | |
---|---|---|---|---|---|---|---|---|
Post | - | - | - | - | - | - | - | - |
Pre | - | - | - | - | - | - | - | - |
AME | |
---|---|
0 | - |
1 | 0.3 |
LOP1 | LOP2 | LOP3 | LOP4 | Total | |
---|---|---|---|---|---|
Post | 0.5 | - | - | - | 0.5 |
Pre | 5.0 | - | - | - | 5.0 |
central brain | |
---|---|
0 | 36.8 |
1 | 202.2 |
Number of post synapses: 1125
Number of pre synapses: 5090
Number of output connections: 19289
Coverage factor: 2.0
Columnar completeness: 0.84
Area completeness: 0.94
Cell size (columns): 296
Number of post synapses: 0
Number of pre synapses: 0
Number of output connections: 0
Coverage factor: 0
Columnar completeness: 0
Area completeness: 0
Cell size (columns): 0
Number of post synapses: 3
Number of pre synapses: 30
Number of output connections: 55
Coverage factor: 1.0
Columnar completeness: 0.01
Area completeness: 0.02
Cell size (columns): 8
instance | NT | total connections | connections /#MeVPMe1 (L) | % | % cumu. | |
---|---|---|---|---|---|---|
0 | Mi4 (R) | GABA | 173 | 28.8 | 15.8% | 15.8% |
1 | Tm4 (R) | ACh | 77 | 12.8 | 7.0% | 22.9% |
2 | Pm4 (R) | GABA | 67 | 11.2 | 6.1% | 29.0% |
3 | Pm9 (R) | GABA | 52 | 8.7 | 4.8% | 33.8% |
4 | TmY5a (R) | Glu | 51 | 8.5 | 4.7% | 38.4% |
5 | Y14 (R) | Glu | 33 | 5.5 | 3.0% | 41.4% |
6 | Mi9 (R) | Glu | 32 | 5.3 | 2.9% | 44.4% |
7 | MeLo8 (R) | GABA | 30 | 5.0 | 2.7% | 47.1% |
8 | Y3 (R) | ACh | 30 | 5.0 | 2.7% | 49.9% |
9 | MeLo9 (R) | Glu | 27 | 4.5 | 2.5% | 52.3% |
10 | Y13 (R) | Glu | 26 | 4.3 | 2.4% | 54.7% |
11 | Tm3 (R) | ACh | 24 | 4.0 | 2.2% | 56.9% |
12 | MeVP4 (R) | ACh | 23 | 3.8 | 2.1% | 59.0% |
13 | Mi14 (R) | Glu | 18 | 3.0 | 1.6% | 60.7% |
14 | Pm12 (R) | Glu | 15 | 2.5 | 1.4% | 62.0% |
15 | MeLo10 (R) | Glu | 14 | 2.3 | 1.3% | 63.3% |
16 | MeVPMe1 (L) | Glu | 14 | 2.3 | 1.3% | 64.6% |
17 | Pm2a (R) | GABA | 14 | 2.3 | 1.3% | 65.9% |
18 | Y12 (R) | Glu | 14 | 2.3 | 1.3% | 67.2% |
19 | MeLo1 (R) | ACh | 13 | 2.2 | 1.2% | 68.3% |
20 | Mi2 (R) | Glu | 13 | 2.2 | 1.2% | 69.5% |
21 | T2a (R) | ACh | 13 | 2.2 | 1.2% | 70.7% |
22 | TmY13 (R) | ACh | 13 | 2.2 | 1.2% | 71.9% |
23 | OA-AL2i1 (R) | OA | 12 | 2.0 | 1.1% | 73.0% |
24 | Tm1 (R) | ACh | 11 | 1.8 | 1.0% | 74.0% |
25 | Mi19 (R) | 5HT | 10 | 1.7 | 0.9% | 74.9% |
26 | TmY18 (R) | ACh | 10 | 1.7 | 0.9% | 75.8% |
27 | MeLo7 (R) | ACh | 9 | 1.5 | 0.8% | 76.7% |
28 | TmY16 (R) | Glu | 9 | 1.5 | 0.8% | 77.5% |
29 | Pm2b (R) | GABA | 8 | 1.3 | 0.7% | 78.2% |
30 | Tm20 (R) | ACh | 8 | 1.3 | 0.7% | 79.0% |
31 | 5-HTPMPV03 (R) | 5HT | 7 | 1.2 | 0.6% | 79.6% |
32 | MeVPLo1 (R) | Glu | 7 | 1.2 | 0.6% | 80.2% |
33 | Tm16 (R) | ACh | 7 | 1.2 | 0.6% | 80.9% |
34 | TmY17 (R) | ACh | 7 | 1.2 | 0.6% | 81.5% |
35 | MeLo11 (R) | Glu | 6 | 1.0 | 0.5% | 82.1% |
36 | MeLo12 (R) | Glu | 6 | 1.0 | 0.5% | 82.6% |
37 | OA-AL2i2 (R) | OA | 6 | 1.0 | 0.5% | 83.2% |
38 | TmY15 (R) | GABA | 6 | 1.0 | 0.5% | 83.7% |
39 | TmY19a (R) | GABA | 6 | 1.0 | 0.5% | 84.3% |
40 | TmY21 (R) | ACh | 6 | 1.0 | 0.5% | 84.8% |
41 | TmY4 (R) | ACh | 6 | 1.0 | 0.5% | 85.4% |
instance | NT | total connections | connections /#MeVPMe1 (L) | % | % cumu. | |
---|---|---|---|---|---|---|
0 | Y3 (R) | ACh | 4,086 | 681.0 | 21.2% | 21.2% |
1 | Tm4 (R) | ACh | 2,426 | 404.3 | 12.6% | 33.8% |
2 | MeLo9 (R) | Glu | 1,840 | 306.7 | 9.5% | 43.3% |
3 | MeLo8 (R) | GABA | 1,460 | 243.3 | 7.6% | 50.9% |
4 | TmY16 (R) | Glu | 1,182 | 197.0 | 6.1% | 57.0% |
5 | TmY14 (R) | Glu | 1,041 | 173.5 | 5.4% | 62.4% |
6 | Y13 (R) | Glu | 999 | 166.5 | 5.2% | 67.6% |
7 | Y12 (R) | Glu | 850 | 141.7 | 4.4% | 72.0% |
8 | MeVP17 (R) | Glu | 606 | 101.0 | 3.1% | 75.1% |
9 | MeLo13 (R) | Glu | 589 | 98.2 | 3.1% | 78.2% |
10 | Pm4 (R) | GABA | 357 | 59.5 | 1.9% | 80.0% |
11 | Mi14 (R) | Glu | 351 | 58.5 | 1.8% | 81.9% |
12 | Y11 (R) | Glu | 280 | 46.7 | 1.5% | 83.3% |
13 | MeVPLo1 (R) | Glu | 219 | 36.5 | 1.1% | 84.5% |
14 | Mi2 (R) | Glu | 213 | 35.5 | 1.1% | 85.6% |
15 | MeVP18 (R) | unclear | 187 | 31.2 | 1.0% | 86.5% |
16 | TmY5a (R) | Glu | 177 | 29.5 | 0.9% | 87.5% |
17 | TmY21 (R) | ACh | 175 | 29.2 | 0.9% | 88.4% |
18 | Mi16 (R) | GABA | 150 | 25.0 | 0.8% | 89.1% |
19 | TmY13 (R) | ACh | 149 | 24.8 | 0.8% | 89.9% |
20 | TmY18 (R) | ACh | 143 | 23.8 | 0.7% | 90.6% |
21 | Cm7 (R) | Glu | 136 | 22.7 | 0.7% | 91.4% |
22 | Pm3 (R) | GABA | 122 | 20.3 | 0.6% | 92.0% |
23 | MeVP26 (R) | unclear | 106 | 17.7 | 0.5% | 92.5% |
24 | MeVP51 (R) | Glu | 100 | 16.7 | 0.5% | 93.1% |
25 | Tm5Y (R) | ACh | 86 | 14.3 | 0.4% | 93.5% |
26 | Tm3 (R) | ACh | 79 | 13.2 | 0.4% | 93.9% |
27 | MeVPMe2 (R) | Glu | 78 | 13.0 | 0.4% | 94.3% |
28 | Cm34 (R) | Glu | 74 | 12.3 | 0.4% | 94.7% |
29 | Y14 (R) | Glu | 70 | 11.7 | 0.4% | 95.1% |
30 | Mi19 (R) | 5HT | 67 | 11.2 | 0.3% | 95.4% |
31 | LPT54 (R) | ACh | 62 | 10.3 | 0.3% | 95.7% |
32 | MeVPMe1 (R) | Glu | 57 | 9.5 | 0.3% | 96.0% |
33 | MeVP23 (R) | unclear | 55 | 9.2 | 0.3% | 96.3% |
34 | T2a (R) | ACh | 37 | 6.2 | 0.2% | 96.5% |
35 | Mi4 (R) | GABA | 33 | 5.5 | 0.2% | 96.7% |
36 | Pm9 (R) | GABA | 33 | 5.5 | 0.2% | 96.8% |
37 | TmY9a (R) | ACh | 23 | 3.8 | 0.1% | 97.0% |
38 | TmY4 (R) | ACh | 22 | 3.7 | 0.1% | 97.1% |
39 | Pm2a (R) | GABA | 20 | 3.3 | 0.1% | 97.2% |
40 | MeLo7 (R) | ACh | 19 | 3.2 | 0.1% | 97.3% |
41 | MeVC1 (L) | ACh | 18 | 3.0 | 0.1% | 97.4% |
42 | TmY3 (R) | ACh | 16 | 2.7 | 0.1% | 97.5% |
43 | MeLo3a (R) | ACh | 15 | 2.5 | 0.1% | 97.5% |
44 | Pm13 (R) | Glu | 15 | 2.5 | 0.1% | 97.6% |
45 | TmY10 (R) | ACh | 15 | 2.5 | 0.1% | 97.7% |
46 | Cm3 (R) | GABA | 14 | 2.3 | 0.1% | 97.8% |
47 | MeVPMe1 (L) | Glu | 14 | 2.3 | 0.1% | 97.8% |
48 | Pm8 (R) | GABA | 14 | 2.3 | 0.1% | 97.9% |
49 | MeVP3 (R) | ACh | 13 | 2.2 | 0.1% | 98.0% |
50 | Pm12 (R) | Glu | 13 | 2.2 | 0.1% | 98.0% |
51 | Tm12 (R) | ACh | 13 | 2.2 | 0.1% | 98.1% |
52 | Tm38 (R) | ACh | 13 | 2.2 | 0.1% | 98.2% |
53 | Pm2b (R) | GABA | 12 | 2.0 | 0.1% | 98.2% |
54 | T3 (R) | ACh | 12 | 2.0 | 0.1% | 98.3% |
55 | Tm1 (R) | ACh | 12 | 2.0 | 0.1% | 98.4% |
56 | Tm16 (R) | ACh | 12 | 2.0 | 0.1% | 98.4% |
57 | Lawf2 (R) | ACh | 11 | 1.8 | 0.1% | 98.5% |
58 | T2 (R) | ACh | 11 | 1.8 | 0.1% | 98.5% |
59 | Mi9 (R) | Glu | 10 | 1.7 | 0.1% | 98.6% |
60 | Tm39 (R) | ACh | 10 | 1.7 | 0.1% | 98.6% |
61 | OA-AL2i1 (R) | OA | 9 | 1.5 | 0.0% | 98.7% |
62 | Tm35 (R) | Glu | 9 | 1.5 | 0.0% | 98.7% |
63 | Tm5b (R) | ACh | 9 | 1.5 | 0.0% | 98.8% |
64 | MeVP48 (R) | unclear | 8 | 1.3 | 0.0% | 98.8% |
65 | Mi13 (R) | Glu | 8 | 1.3 | 0.0% | 98.9% |
66 | TmY15 (R) | GABA | 8 | 1.3 | 0.0% | 98.9% |
67 | MeTu1 (R) | ACh | 7 | 1.2 | 0.0% | 98.9% |
68 | MeVP4 (R) | ACh | 7 | 1.2 | 0.0% | 99.0% |
69 | Tm6 (R) | ACh | 7 | 1.2 | 0.0% | 99.0% |
70 | TmY19a (R) | GABA | 7 | 1.2 | 0.0% | 99.1% |
71 | TmY9b (R) | ACh | 7 | 1.2 | 0.0% | 99.1% |
72 | Ascending_TBD1 (R) | unclear | 6 | 1.0 | 0.0% | 99.1% |
73 | LPi2c (R) | Glu | 6 | 1.0 | 0.0% | 99.2% |
74 | MeLo10 (R) | Glu | 6 | 1.0 | 0.0% | 99.2% |
75 | Tm32 (R) | Glu | 6 | 1.0 | 0.0% | 99.2% |
76 | Tm37 (R) | Glu | 6 | 1.0 | 0.0% | 99.2% |
77 | Tm5a (R) | ACh | 6 | 1.0 | 0.0% | 99.3% |
78 | Tm9 (R) | ACh | 6 | 1.0 | 0.0% | 99.3% |